0

BANZEL از شرکت EISAI INC

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

BANZEL از شرکت EISAI INC

New Drug Application (NDA): 201367

Company: EISAI INC

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
BANZEL RUFINAMIDE 40MG/ML SUSPENSION;ORAL Prescription

AB

Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
03/03/2011 ORIG-1 Approval

Type 3 – New Dosage Form

STANDARD; Orphan

Label (PDF)

Letter (PDF)

Review

Summary Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/0201367,021911s007lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/201367s000,021911s007ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/201367_banzel_toc.cfm
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/201367Orig1s000SumR.pdf

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
11/28/2019 SUPPL-8 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021911s017,201367s008lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021911Orig1s017,201367Orig1s008ltr.pdf

10/06/2015 SUPPL-6 Manufacturing (CMC)

Label is not available on this site.

06/25/2015 SUPPL-5 Labeling-Package Insert, Labeling-Patient Package Insert, Labeling-Medication Guide

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021911Orig1s013, 201367Orig1s005lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021911Orig1s013,201367Orig1s005ltr.pdf

02/12/2015 SUPPL-3 Efficacy-Labeling Change With Clinical Data

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021911s012lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021911Orig1s012,201367Orig1s003ltr.pdf

01/05/2015 SUPPL-2 Manufacturing (CMC)

Label is not available on this site.

06/10/2011 SUPPL-1 REMS-Modified

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021911s008,201367s001ltr.pdf

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
11/28/2019 SUPPL-8

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021911s017,201367s008lbl.pdf
06/25/2015 SUPPL-5

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021911Orig1s013, 201367Orig1s005lbl.pdf
06/25/2015 SUPPL-5

Labeling-Patient Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021911Orig1s013, 201367Orig1s005lbl.pdf
06/25/2015 SUPPL-5

Labeling-Medication Guide

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021911Orig1s013, 201367Orig1s005lbl.pdf
02/12/2015 SUPPL-3

Efficacy-Labeling Change With Clinical Data

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021911s012lbl.pdf
03/03/2011 ORIG-1 Approval

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/0201367,021911s007lbl.pdf

BANZEL

SUSPENSION;ORAL; 40MG/ML

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
BANZEL RUFINAMIDE 40MG/ML SUSPENSION;ORAL Prescription Yes AB 201367 EISAI INC
RUFINAMIDE RUFINAMIDE 40MG/ML SUSPENSION;ORAL Prescription No AB 213410 ALKEM LABS LTD
RUFINAMIDE RUFINAMIDE 40MG/ML SUSPENSION;ORAL Prescription No AB 211388 BIONPHARMA INC
RUFINAMIDE RUFINAMIDE 40MG/ML SUSPENSION;ORAL Prescription No AB 207363 HIKMA
RUFINAMIDE RUFINAMIDE 40MG/ML SUSPENSION;ORAL Prescription No AB 213457 LUPIN LTD
برچسب‌ها:

نظرات کاربران